Genetic Disorder Cluster Muscular Dystrophy Drug Development Report 2017.
This report provides an overview of the genetic disorders pipeline landscape, specifically focusing on muscular dystrophies.
The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Becker and Duchene Muscular Dystrophy (BMD and DMD) and features dormant and discontinued projects.
Both indications covered are inherited muscular dystrophies, a group of genetic, degenerative diseases primarily affecting voluntary muscles.
The size of these two pipelines ranges from just six in BMD to 108 in DMD. The majority of pipeline products for DMD target dystrophin which, as mentioned, is the causative gene for the disease.
The size of these two pipelines ranges from just six in BMD to 108 in DMD. The majority of pipeline products for DMD target dystrophin which, as mentioned, is the causative gene for the disease.
Scope
- Which companies are the most active within the pipeline for genetic disorder therapeutics?
- Which companies are the most active within the pipeline for genetic disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of genetic disorder therapeutics?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.
Related Reports:
Global Genetic Testing Market Outlook 2022
2016 Global Genetically Modified Food Safety TestingMarket Status, 2011-2022 Market Historical, and Forecasts, Professional Market Research Report
View Full Reports Here:
Contact Us:
+ (91) 9987295242.
Website:
Comments
Post a Comment